COPD

A novel device that unblocks and removes secretions from the respiratory tracts of children was developed by researchers in Israel and the United States, and may prove beneficial among patients with respiratory diseases such as chronic obstructive pulmonary disease (COPD).

Adjunctive therapy with a positive expiratory pressure (PEP) device may possibly decrease the length of hospital stays for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), researchers suggested in a set of 2 small studies published in the International Journal of Chronic Obstructive Pulmonary Disease.

An international study examining trends in COPD mortality over more than 2 decades showed that COPD mortality rates declined in most countries, but remained stable among US women and increased in several European countries, with total mortality additionally increasing or remaining stable in most countries.

As part of its Quality Improvement Snapshots series, TMF Health Quality Institute issued 4 healthcare quality improvement efforts, highlighting the use of a rescue pack for patients with chronic obstructive pulmonary disease (COPD) as an impactful strategy in managing COPD-related exacerbations.

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.

Clinical characteristics of women with chronic obstructive pulmonary disease (COPD) are important for primary care clinicians to consider in order to improve COPD awareness since women often go underdiagnosed, according to results from a recent study.

Researchers proposed new diagnostic criteria for chronic obstructive pulmonary disease (COPD) that seek to identify more patients in early stages of the disease, promote better care for patients, and stimulate research to slow and prevent COPD, in a paper published today in the journal Chronic Obstructive Pulmonary Diseases.

Socially deprived patients were younger, more frequently women, active smokers, living alone, and belonged to lower socioprofessional categories when compared with the non-socially deprived group, but they still benefitted from home-based pulmonary rehabilitation.

The use of fluticasone-containing inhaled corticosteroids (ICS) was linked to increased risk of pneumonia in patients with COPD, according to study findings.

A review evaluating the methodological approaches of identifying chronic obstructive pulmonary disease (COPD) found that when more criteria is combined, the more accurate the detection of COPD in terms of sensitivity and specificity.

Regular use of chemical disinfectants among female nurses was found to be a potential risk factor for the development of chronic obstructive pulmonary disease (COPD), according to study findings.

Patients with severe chronic obstructive pulmonary disorder (COPD) and chronic bronchial infection due to Pseudomonas aeruginosa may benefit from combination therapy with nebulized colistin and continuous cyclic azithromycin for reducing the number of COPD exacerbations.

People who are former smokers or who smoke fewer than 5 cigarettes a day were shown to have long-term damage to their lungs, which can increase the risk of developing chronic obstructive pulmonary disease, according to a study.

A smart mobile health tool that supports patients with chronic obstructive pulmonary disease (COPD) may be an effective alternative to a paper action plan for self-management of exacerbations.

Two recent abstracts presented at the European Respiratory Society International Congress investigated the decision-making and care management for chronic obstructive pulmonary disease (COPD) patients.

Enrollment in a high-deductible health plan was shown to be associated with cost-related barriers to care, financial strain, and more frequent emergency department (ED) visits and hospitalizations for patients with chronic obstructive pulmonary disease (COPD), according to a study.

Enrollment in a high-deductible health plan was shown to be associated with cost-related barriers to care, financial strain, and more frequent emergency department (ED) visits and hospitalizations for patients with chronic obstructive pulmonary disease (COPD), according to a study.

JAMA on Tuesday retracted and republished a 2018 study about chronic obstructive pulmonary disease (COPD) after the discovery of a programming error in the statistical analysis. The subsequent complete reanalysis by the authors showed that the intervention that was studied showed harm, rather than benefit, to patients.

Use of wrist-worn step trackers were shown to accurately estimate exercise capacity and determine the health status of patients with COPD and cardiovascular diseases, based off research presented at the 2019 European Respiratory Society Congress.

Researchers have proposed a new tool and framework involving a personalized approach for managing chronic obstructive pulmonary disease (COPD) and the use of inhaled corticosteroids.

Patients with severe persistent asthma or severe COPD, with additional inclinations toward anxiety or panic disorders, exhibited an increased interest in using digital inhalers, based off 2 Health Union condition-specific surveys.

A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.

Older adults above the age of 66 with COPD were found to be twice as likely to use prescription synthetic oral cannabinoids when compared with adults of the same age without COPD, according to a study.

Patients who reported feeling lonely had worse health ratings, 6-minute walk tests, and breathlessness.

A link between a genetic risk score (GRS) related to chronic obstructive pulmonary disease (COPD) susceptibility and computed tomagraphy (CT) lung structure was found, indicating the possible use of lung structure data to determine COPD risk, according to a new study.